Portal hypertension in biliary atresia: a Japanese biliary atresia registry study
Pediatric Surgery International · 31.10.2025 · 41 (1)
DOI: 10.1007/s00383-025-06222-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Surgery International, online erschienen am 31.10.2025. Verfasst von Ryuji Okubo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. Hauptthemen laut MEDLINE: Biliary Atresia, Hypertension, Portal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the MHLW Research on Rare and Intractable Diseases Program.
Abstract (Originalsprache)
Purpose
This study aimed to clarify the incidence of portal hypertension (PH) in biliary atresia (BA), its impact on long-term native liver survival rates (NLSRs), and the role of PH treatment.
Methods
Data were analyzed from 3,777 patients in the Japanese Biliary Atresia Registry (1989–2021). Incidence and treatment of PH were examined in all patients and in 20-year native liver survivors. A subgroup of 596 jaundice-free native liver survivors was divided into three groups: without PH (A), untreated PH (B), and treated PH (C). Patient characteristics, clinical outcomes, and survival analyses were performed.
Results
PH occurred in 46.4% of all patients, with gastroesophageal varices (35.1%) and hypersplenism (36.8%) being most common. Among 759 20-year native liver survivors, 49.8% had PH, largely diagnosed between 2 and 15 years. Group C patients were older at Kasai portoenterostomy and had more cholangitis. Survival analysis showed best outcomes in group A and worst in group C. Conditional native liver survival analysis revealed group B initially had better NLSRs than group C, but differences diminished beyond 15 years.
Conclusion
In native liver survivors without jaundice following KP, PH influenced prognosis, but successful treatment enabled long-term survival comparable to patients with mild or no PH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
- Department of Surgery, Miyagi Children's Hospital, 4-3-17, Ochiai, Aoba-ku, Sendai, Miyagi, 989-3126, Japan.
- Division of Pediatric Surgery, Department of Surgery II, Faculty of Medicine, Yamagata University, 2-2-2 Iidanishi, Yamagata, 990-9585, Japan.
- Department of Pediatric Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. wada@ped-surg.med.tohoku.ac.jp.
Förderung
- the MHLW Research on Rare and Intractable Diseases Program
Zitieren
APA
Okubo, R., Nio, M., Sasaki, H., Fukuzawa, T., Kudo, H., Ando, R., Sakurai, T., Hashimoto, M., Tada, K., Wada, M., & Japanese Biliary Atresia Society (2025). Portal hypertension in biliary atresia: a Japanese biliary atresia registry study. Pediatric Surgery International, 41(1). https://doi.org/10.1007/s00383-025-06222-4
Vancouver
Okubo R, Nio M, Sasaki H, Fukuzawa T, Kudo H, Ando R, et al. Portal hypertension in biliary atresia: a Japanese biliary atresia registry study. Pediatric Surgery International. 2025;41(1). doi:10.1007/s00383-025-06222-4
BibTeX
@article{Okubo2025,
author = {Okubo, Ryuji and Nio, Masaki and Sasaki, Hideyuki and Fukuzawa, Taichi and Kudo, Hironori and Ando, Ryo and Sakurai, Tsuyoshi and Hashimoto, Masatoshi and Tada, Keisuke and Wada, Motoshi and Japanese Biliary Atresia Society, Japanese Biliary Atresia Society},
title = {Portal hypertension in biliary atresia: a Japanese biliary atresia registry study},
journal = {Pediatric Surgery International},
year = {2025},
volume = {41},
number = {1},
doi = {10.1007/s00383-025-06222-4}
}
EUVIMED